INTRODUCTION: Bradykinesia is an essential diagnostic criterion for Parkinson's disease (PD) but is frequently observed in many non-parkinsonian movement disorders, complicating differential diagnosis, particularly in disorders featuring tremors. The presence of bradykinetic features in the subset of dystonic tremors (DT), either "pure" dystonic tremors or tremors associated with dystonia, remains currently unexplored. The aim of the current study was to evaluate upper limb bradykinesia in DT patients, comparing them with healthy controls (HC) and patients with PD by observing repetitive finger tapping (FT). METHODS: The protocol consisted of two main parts. Initially, the kinematic recording of repetitive FT was performed using optical hand tracking system (Leap Motion Controller). The values of amplitude, amplitude decrement, frequency, frequency decrement, speed, acceleration and number of halts of FT were calculated. Subsequently, three independent movement disorder specialists from different movement disorders centres, blinded to the diagnosis, rated the presence of FT bradykinesia based on video recordings. RESULTS: Thirty-six subjects participated in the study (12 DT, 12 HC and 12 early-stage PD). Kinematic analysis revealed no significant difference in the selected parameters of FT bradykinesia between DT patients and HC. In comparisons between DT and PD patients, PD patients exhibited bigger amplitude decrement and slower FT performance. In the blinded clinical assessment, bradykinesia was rated, on average, as being present in 41.6% of DT patients, 27.7% of HC, and 91.7% of PD patients. While overall inter-rater agreement was moderate, weak agreement was noted within the DT group. DISCUSSION: Clinical ratings indicated signs of bradykinesia in almost half of DT patients. The objective kinematic analysis confirmed comparable parameters between DT and HC individuals, with more pronounced abnormalities in PD across various kinematic parameters. Interpretation of bradykinesia signs in tremor patients with DT should be approached cautiously and objective motion analysis might complement the diagnostic process and serve as a decision support system in the choice of clinical entities.

1st Department of Neurology St Anne's University Hospital Masaryk University Brno Czechia

2nd Department of Neurology Faculty of Medicine Comenius University Bratislava Slovakia

Central European Institute of Technology Brno Czechia

Centre for Psychiatric Disorders Research Science Park Comenius University in Bratislava Bratislava Slovakia

Department of Psychiatry Faculty of Medicine Comenius University Bratislava Slovakia

Department of Psychology Faculty of Arts Comenius University Bratislava Slovakia

Institute of Normal and Pathological Physiology Center of Experimental Medicine Slovak Academy of Sciences Bratislava Slovakia

Institute of Robotics and Cybernetics Faculty of Electrical Engineering and Informatics Slovak University of Technology in Bratislava Bratislava Slovakia

See more in PubMed

Apartis E. (2013). “Clinical neurophysiology in movement disorders,” in Handbook of clinical neurology, pediatric neurology part I, eds Dulac O., Lassonde M., Sarnat H. B. (Amsterdam: Elsevier; ), 87–92. PubMed

Arceneaux J. M., Kirkendall D. J., Hill S. K., Dean R. S., Anderson J. L. (1997). Validity and reliability of rapidly alternating movement tests. Int. J. Neurosci. 89 281–286. PubMed

Benecke R., Rothwell J. C., Dick J. P., Day B. L., Marsden C. D. (1987). Disturbance of sequential movements in patients with Parkinson’s disease. Brain 110 361–379. PubMed

Bennett D. A., Shannon K. M., Beckett L. A., Goetz C. G., Wilson R. S. (1997). Metric properties of nurses’ ratings of Parkinsonian signs with a modified unified Parkinson’s disease rating scale. Neurology 49 1580–1587. 10.1212/wnl.49.6.1580 PubMed DOI

Bhatia K. P., Bain P., Bajaj N., Elble R. J., Hallett M., Louis E. D., et al. (2018). Tremor task force of the international parkinson and movement disorder society. Mov. Disord. 33 75–87. PubMed PMC

Bologna M., Espay A. J., Fasano A., Paparella G., Hallett M., Berardelli A. (2023). Redefining Bradykinesia. Mov. Disord. 38 551–557. PubMed PMC

Bologna M., Paparella G., Colella D., Cannavacciuolo A., Angelini L., Alunni-Fegatelli D., et al. (2020). Is there evidence of Bradykinesia in essential tremor? Eur. J. Neurol. 27 1501–1509. PubMed

Brown V. A. (2021). An introduction to linear mixed-effects modeling in R. Adv. Methods Pract. Psychol. Sci. 4:2515245920960351.

Butt A. H., Rovini E., Dolciotti C., De Petris G., Bongioanni P., Carboncini M. C., et al. (2018). Objective and automatic classification of Parkinson disease with leap motion controller. BioMed. Eng. Online 17:68. 10.1186/s12938-018-0600-7 PubMed DOI PMC

Constantinides V. C., Paraskevas G. P., Paraskevas P. G., Stefanis L., Kapaki E. (2019). Corticobasal degeneration and corticobasal syndrome: A review. Clin. Parkinson. Relat. Disord. 1 66–71. PubMed PMC

de Deus Fonticoba T., Santos García D., Macías Arribí M. (2019). Inter-rater variability in motor function assessment in Parkinson’s disease between experts in movement disorders and nurses specialising in PD management. Neurologia 34 520–526. 10.1016/j.nrl.2017.03.005 PubMed DOI

Deuschl G. (2003). Dystonic tremor. Rev. Neurol. 159 900–905. PubMed

Djurić-Jovičić M., Jovičić N. S., Roby-Brami A., Popović M. B., Kostić V. S., Djordjević A. R. (2017). Quantification of finger-tapping angle based on wearable sensors. Sensors 17:203. 10.3390/s17020203 PubMed DOI PMC

Fahn S., Tolosa E., Marín C. (1988). “Clinical rating scale for tremor,” in Parkinson’s disease and movement disorders, eds Jankovic J., Tolosa E. (Baltimore, MD: Williams & Wilkins; ), 225–234.

Frolov N. S., Pitsik E. N., Maksimenko V. A., Grubov V. V., Kiselev A. R., Wang Z., et al. (2020). Age-related slowing down in the motor initiation in elderly adults. PLoS One 15:e0233942. 10.1371/journal.pone.0233942 PubMed DOI PMC

Gamboa E., Serrato A., Castro J., Toro D., Trujillo M. (2020). Advantages and limitations of leap motion from a developers’, physical therapists’, and patients’ perspective. Methods Inf. Med. 59 110–116. 10.1055/s-0040-1715127 PubMed DOI

Garcia-Agundez A., Eickhoff C. (2021). Towards objective quantification of hand tremors and Bradykinesia using contactless sensors: A systematic review. Front. Aging Neurosci. 13:716102. 10.3389/fnagi.2021.716102 PubMed DOI PMC

Goetz C. G., Stebbins G. T. (2004). Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov. Disord. 19 1453–1456. 10.1002/mds.20213 PubMed DOI

Haggstrom L., Darveniza P., Tisch S. (2017). Mild parkinsonian features in dystonia: Literature review, mechanisms and clinical perspectives. Parkinson. Relat. Disord. 35 1–7. 10.1016/j.parkreldis.2016.10.022 PubMed DOI

Hallett M. (2000). Disorder of movement preparation in dystonia. Brain 123 1765–1766. PubMed

Hasan H., Athauda D. S., Foltynie T., Noyce A. J. (2017). Technologies assessing limb Bradykinesia in Parkinson’s disease. J. Parkinsons Dis. 7 65–77. PubMed PMC

Jain S., Lo S. E., Louis E. D. (2006). Common misdiagnosis of a common neurological disorder: How are we misdiagnosing essential tremor? Arch. Neurol. 63 1100–1104. PubMed

Lee W. L., Sinclair N. C., Jones M., Tan J. L., Proud E. L., Peppard R., et al. (2019). Objective evaluation of Bradykinesia in Parkinson’s disease using an inexpensive marker-less motion tracking system. Physiol. Meas. 40:014004. 10.1088/1361-6579/aafef2 PubMed DOI

Ling H., Massey L. A., Lees A. J., Brown P., Day B. L. (2012). Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135 1141–1153. 10.1093/brain/aws038 PubMed DOI PMC

Marsili L., Duque K. R., Gregor N., Abdelghany E., Abanto J., Duker A. P., et al. (2023). Bradykinesia in neurodegenerative disorders: A blinded video analysis of pathology-proven cases. Mov. Disord. 38 496–501. 10.1002/mds.29330 PubMed DOI

Morales-Briceno H., Fung V. S. C., Bhatia K. P., Balint B. (2022). Parkinsonism and dystonia: Clinical spectrum and diagnostic clues. J. Neurol. Sci. 433:120016. PubMed

Murgai A. A., Jog M. (2020). Focal limb dystonia and tremor: Clinical update. Toxicon 176 10–14. PubMed

Nasreddine Z. S., Phillips N. A., Bédirian V., Charbonneau S., Whitehead V., Collin I., et al. (2005). The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53 695–699. 10.1111/j.1532-5415.2005.53221.x PubMed DOI

Panyakaew P., Jinnah H. A., Shaikh A. G. (2022). Clinical features, pathophysiology, treatment, and controversies of tremor in dystonia. J. Neurol. Sci. 435:120199. PubMed PMC

Paparella G., Fasano A., Hallett M., Berardelli A., Bologna M. (2021). Emerging concepts on Bradykinesia in non-Parkinsonian conditions. Eur. J. Neurol. 28 2403–2422. 10.1111/ene.14851 PubMed DOI

Paparella G., Guerra A., Galosi S., Cannavacciuolo A., Angelini L., Popa T., et al. (2023). Bradykinesia and dystonia. Dystonia 2:11448.

Postuma R. B., Berg D., Stern M., Poewe W., Olanow C. W., Oertel W., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. 30 1591–1601. PubMed

Ross A., Willson V. L. (2017). “Paired samples T-test,” in Basic and advanced statistical tests: Writing results sections and creating tables and figures, eds Ross A., Willson V. L. (Rotterdam: Sense Publishers; ), 17–19.

Saling L. L., Phillips J. G. (2008). Age-related slowing of movement as basal ganglia dysfunction. Eur. Rev. Aging Phys. Act 5 69–77.

Schilder J. C. M., Overmars S. S., Marinus J., van Hilten J. J., Koehler P. J. (2017). The terminology of Akinesia, Bradykinesia and Hypokinesia: Past, present and future. Parkinson. Relat. Disord. 37 27–35. 10.1016/j.parkreldis.2017.01.010 PubMed DOI

Schneider S. A., Edwards M. J., Mir P., Cordivari C., Hooker J., Dickson J., et al. (2007). Patients with adult-onset dystonic tremor resembling Parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov. Disord. 22 2210–2215. 10.1002/mds.21685 PubMed DOI

Thijssen E., Makai-Bölöni S., van Brummelen E., den Heijer J., Yavuz Y., Doll R.-J., et al. (2022). A placebo-controlled study to assess the sensitivity of finger tapping to medication effects in Parkinson’s disease. Mov. Disord. Clin. Pract. 9 1074–1084. 10.1002/mdc3.13563 PubMed DOI PMC

Tinaz S., Pillai A. S., Hallett M. (2016). Sequence effect in Parkinson’s disease is related to motor energetic cost. Front. Neurol. 7:83. 10.3389/fneur.2016.00083 PubMed DOI PMC

Williams S., Wong D., Alty J. E., Relton S. D. (2023). Parkinsonian hand or clinician’s eye? Finger tap Bradykinesia interrater reliability for 21 movement disorder experts. J. Parkinsons Dis. 13 525–536. PubMed PMC

Yu T., Park K. W., McKeown M. J., Wang Z. J. (2023). Clinically informed automated assessment of finger tapping videos in Parkinson’s disease. Sensors 23:9149. 10.3390/s23229149 PubMed DOI PMC